Shapiro S - Search Results

1

Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report.

Maciel M Jr, Amara RR, Bar KJ, Crotty S, Deeks SG, Duplessis C, Gaiha G, McElrath MJ, McMichael A, Palin A, Rutishauser R, Shapiro S, Smiley ST, D'Souza MP. Maciel M Jr, et al. Among authors: shapiro s. NPJ Vaccines. 2024 Feb 21;9(1):39. doi: 10.1038/s41541-024-00818-y. NPJ Vaccines. 2024. PMID: 38383616 Free PMC article.

2

Workshop summary: Novel biomarkers for HIV incidence assay development.

Sharma UK, Schito M, Welte A, Rousseau C, Fitzgibbon J, Keele B, Shapiro S, McMichael A, Burns DN. Sharma UK, et al. Among authors: shapiro s. AIDS Res Hum Retroviruses. 2012 Jun;28(6):532-9. doi: 10.1089/aid.2011.0332. Epub 2012 Feb 24. AIDS Res Hum Retroviruses. 2012. PMID: 22206265 Free PMC article.

3

Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report.

Maciel M Jr, Amara RR, Bar KJ, Crotty S, Deeks SG, Duplessis C, Gaiha G, McElrath MJ, McMichael A, Palin A, Rutishauser R, Shapiro S, Smiley ST, D'Souza MP. Maciel M Jr, et al. Among authors: shapiro s. NPJ Vaccines. 2024 Mar 14;9(1):61. doi: 10.1038/s41541-024-00852-w. NPJ Vaccines. 2024. PMID: 38485736 Free PMC article. No abstract available.

4

A proposal to use iterative, small clinical trials to optimize therapeutic HIV vaccine immunogens to launch therapeutic HIV vaccine development.

Shapiro SZ. Shapiro SZ. AIDS Res Hum Retroviruses. 2015 Jan;31(1):49-55. doi: 10.1089/AID.2014.0172. AIDS Res Hum Retroviruses. 2015. PMID: 25286142 Free PMC article.

5

HIV vaccine development: strategies for preclinical and clinical investigation.

Shapiro SZ. Shapiro SZ. AIDS Res Hum Retroviruses. 2013 Nov;29(11):1401-6. doi: 10.1089/AID.2012.0337. Epub 2013 Mar 8. AIDS Res Hum Retroviruses. 2013. PMID: 23379343 Free PMC article. Review.

6

Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?

Sheets RL, Rangavajhula V, Pullen JK, Butler C, Mehra V, Shapiro S, Pensiero M. Sheets RL, et al. Among authors: shapiro s. Vaccine. 2015 Apr 8;33(15):1757-66. doi: 10.1016/j.vaccine.2015.02.003. Epub 2015 Feb 16. Vaccine. 2015. PMID: 25698494 Free PMC article. Review.

7

Lessons for general vaccinology research from attempts to develop an HIV vaccine.

Shapiro SZ. Shapiro SZ. Vaccine. 2019 Jun 6;37(26):3400-3408. doi: 10.1016/j.vaccine.2019.04.005. Epub 2019 Apr 9. Vaccine. 2019. PMID: 30979571 Review.

8

HIV Vaccine Development: 35 Years of Experimenting in the Funding of Biomedical Research.

Shapiro SZ. Shapiro SZ. Viruses. 2020 Dec 19;12(12):1469. doi: 10.3390/v12121469. Viruses. 2020. PMID: 33352755 Free PMC article. Review.

9

Clinical development of candidate HIV vaccines: different problems for different vaccines.

Shapiro SZ. Shapiro SZ. AIDS Res Hum Retroviruses. 2014 Apr;30(4):325-9. doi: 10.1089/AID.2013.0114. Epub 2013 Nov 22. AIDS Res Hum Retroviruses. 2014. PMID: 24168166 Free PMC article. Review.

10

The HIV/AIDS vaccine researchers' orientation to the process of preparing a US FDA application for an investigational new drug (IND): what it is all about and how you start by preparing for your pre-IND meeting.

Shapiro SZ. Shapiro SZ. Vaccine. 2002 Jan 31;20(9-10):1261-80. doi: 10.1016/s0264-410x(01)00453-4. Vaccine. 2002. PMID: 11818145 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,931 results

Search Page

Filters